BMD loss occurs early in androgen deprivation therapy

BMD loss occurs early in androgen deprivation therapy

(HealthDay) -- The highest average change in bone mineral density (BMD) occurs during early treatment of nonmetastatic, hormone-sensitive prostate cancer in men receiving intermittent androgen deprivation therapy (ADT), according to research published online April 9 in the Journal of Clinical Oncology.

Evan Y. Yu, M.D., of the University of Washington/Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted a study involving 56 men with nonmetastatic, hormone-sensitive to measure the changes in BMD and associated with each cycle of nine months of treatment with intermittent ADT with leuprolide and flutamide.

The researchers found that, during the first on-treatment period, the decrease in spinal BMD averaged 3.4 percent and the decrease in left hip BMD averaged 1.2 percent; both changes were statistically significant. Spine BMD recovery during the first off-treatment period was significant, with an average increase of 1.4 percent. No significant average changes were observed during subsequent treatment periods. After a median of 5.5 years on trial, one patient (1.8 percent) had a trauma-associated compression fracture.

"To our knowledge, this study is the first to evaluate the dynamics of BMD on intermittent androgen deprivation by looking at DXA scans relative to the treatment cycles of intermittent androgen deprivation. Instead of measuring BMD at baseline and predetermined time points after the initiation of ADT, as was done in the only other report of BMD changes after intermittent androgen deprivation, DXA scans were performed at the beginning of each on- and off-treatment period to more directly assess the impact of testosterone depletion and recovery on BMD changes," the authors write.

Two authors disclosed with Amgen.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Spicy treatment the answer to aggressive cancer?

date Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.